Trailing-twelve-month (TTM) revenue is $124.65 Million with a year-over-year growth of +6.00%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $30,482,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $30,313,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-26 |
| Q1 FY2026Period ended 2026-03-31 | $30,316,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $33,540,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $124,651,000 |
Current P/S: $31,466,408 market capitalization ÷ $124,651,000 TTM revenue = 0.25x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:43:29.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $33.54M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:47:32.926Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2013-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20122012-12-31 · USD | FY20132013-12-31 · USD |
|---|---|---|
| Aerospace and Defense | $15,698 | $20M |
| Industrial | $58,707 | $56M |
| Medical | $32,532 | $35M |
$124.65M
$124.65 Million
+6.00%
vs. $117.60M a year ago (TTM)
+4.00%
5 Year compound annual growth rate
1 Year
+6.00%
3 Year
(3.98%)
5 Year
+4.00%
10 Year
+0.40%
15 Year
+0.83%
20 Year
+1.27%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $118.36M | ($9.77M) | (7.62%) |
| 2024 | $128.13M | ($11.20M) | (8.04%) |
| 2023 | $139.33M | +$5.21M | +3.88% |
| 2022 | $134.12M | +$18.95M | +16.46% |
| 2021 | $115.17M | +$11.06M | +10.63% |
| 2020 |
TTM Growth
+6.00%
3-Year CAGR
(3.98%)
5-Year CAGR
+4.00%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:47:32.926Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $104.11M |
| ($12.23M) |
| (10.51%) |
| 2019 | $116.33M | +$2.96M | +2.61% |
| 2018 | $113.37M | +$1.04M | +0.92% |
| 2017 | $112.33M | ($4.29M) | (3.68%) |
| 2016 | $116.62M | +$1.43M | +1.24% |
